BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31276435)

  • 1. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
    Digomann D; Linge A; Dubrovska A
    Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity.
    Digomann D; Kurth I; Tyutyunnykova A; Chen O; Löck S; Gorodetska I; Peitzsch C; Skvortsova II; Negro G; Aschenbrenner B; Eisenhofer G; Richter S; Heiden S; Porrmann J; Klink B; Schwager C; Dowle AA; Hein L; Kunz-Schughart LA; Abdollahi A; Lohaus F; Krause M; Baumann M; Linge A; Dubrovska A
    Clin Cancer Res; 2019 May; 25(10):3152-3163. PubMed ID: 30670494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
    Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
    Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
    Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma.
    Köseer AS; Loureiro LR; Jureczek J; Mitwasi N; González Soto KE; Aepler J; Bartsch T; Feldmann A; Kunz-Schughart LA; Linge A; Krause M; Bachmann M; Arndt C; Dubrovska A
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
    Nguyen NNT; Lim YS; Nguyen LP; Tran SC; Luong TTD; Nguyen TTT; Pham HT; Mai HN; Choi JW; Han SS; Hwang SB
    Sci Rep; 2018 Oct; 8(1):15486. PubMed ID: 30341327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.
    Nathansen J; Lukiyanchuk V; Hein L; Stolte MI; Borgmann K; Löck S; Kurth I; Baumann M; Krause M; Linge A; Dubrovska A
    Oncogene; 2021 Jun; 40(24):4214-4228. PubMed ID: 34079088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
    Kurth I; Hein L; Mäbert K; Peitzsch C; Koi L; Cojoc M; Kunz-Schughart L; Baumann M; Dubrovska A
    Oncotarget; 2015 Oct; 6(33):34494-509. PubMed ID: 26460734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino Acid Transport Associated to Cluster of Differentiation 98 Heavy Chain (CD98hc) Is at the Cross-road of Oxidative Stress and Amino Acid Availability.
    de la Ballina LR; Cano-Crespo S; González-Muñoz E; Bial S; Estrach S; Cailleteau L; Tissot F; Daniel H; Zorzano A; Ginsberg MH; Palacín M; Féral CC
    J Biol Chem; 2016 Apr; 291(18):9700-11. PubMed ID: 26945935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer.
    Keulers TG; Koch A; van Gisbergen MW; Barbeau LMO; Zonneveld MI; de Jong MC; Savelkouls KGM; Wanders RG; Bussink J; Melotte V; Rouschop KMA
    Autophagy; 2022 Aug; 18(8):1898-1914. PubMed ID: 34904929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD98 heavy chain as a prognostic biomarker and target for cancer treatment.
    Xia P; Dubrovska A
    Front Oncol; 2023; 13():1251100. PubMed ID: 37823053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of lncRNA BLACAT1 enhances radiosensitivity of head and neck squamous cell carcinoma cells by regulating PSEN1.
    Gou C; Han P; Li J; Gao L; Ji X; Dong F; Su Q; Zhang Y; Liu X
    Br J Radiol; 2020 Apr; 93(1108):20190154. PubMed ID: 31944856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior.
    Poettler M; Unseld M; Braemswig K; Haitel A; Zielinski CC; Prager GW
    Mol Cancer; 2013 Dec; 12():169. PubMed ID: 24359579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identify metabolism-related genes IDO1, ALDH2, NCOA2, SLC7A5, SLC3A2, LDHB, and HPRT1 as potential prognostic markers and correlate with immune infiltrates in head and neck squamous cell carcinoma.
    Li C; Chen S; Jia W; Li W; Wei D; Cao S; Qian Y; Guan R; Liu H; Lei D
    Front Immunol; 2022; 13():955614. PubMed ID: 36090994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
    Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
    Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis.
    Naz S; Leiker AJ; Choudhuri R; Preston O; Sowers AL; Gohain S; Gamson J; Mathias A; Van Waes C; Cook JA; Mitchell JB
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1295-1305. PubMed ID: 33838214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma.
    Berggren KL; Restrepo Cruz S; Hixon MD; Cowan AT; Keysar SB; Craig S; James J; Barry M; Ozbun MA; Jimeno A; McCance DJ; Beswick EJ; Gan GN
    Oncogene; 2019 Nov; 38(48):7329-7341. PubMed ID: 31417185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - Hypothesis generation on a multicentre cohort of the DKTK-ROG.
    Löck S; Linge A; Lohaus F; Ebert N; Gudziol V; Nowak A; Tinhofer I; Kalinauskaite G; Guberina M; Stuschke M; Balermpas P; von der Grün J; Grosu AL; Debus J; Ganswindt U; Belka C; Peeken JC; Combs SE; De-Colle C; Zips D; Baretton GB; Krause M; Baumann M;
    Radiother Oncol; 2022 Apr; 169():8-14. PubMed ID: 35182686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drosophila expresses a CD98 transporter with an evolutionarily conserved structure and amino acid-transport properties.
    Reynolds B; Roversi P; Laynes R; Kazi S; Boyd CA; Goberdhan DC
    Biochem J; 2009 May; 420(3):363-72. PubMed ID: 19335336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.